MedPath

Efficacy and Safety of SPARC0921 in Subjects With Spasticity

Phase 3
Completed
Conditions
Spasticity
Interventions
Drug: Placebo0921
Registration Number
NCT01457352
Lead Sponsor
Sun Pharma Advanced Research Company Limited
Brief Summary

The purpose of this study is to assess whether SPARC0921 demonstrate efficacy and safety in the treatment of spasticity.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
392
Inclusion Criteria
  • Men and women age 18 years and older
  • Able and willing to comply with the protocol, including availability for a scheduled clinic visits
  • Willingness and giving of written informed consent
Exclusion Criteria
  • In relapse or history of unstable course over the prior 30 days prior to the Screening Visit
  • Concomitant neurologic conditions causing spasticity
  • Has received an investigational drug or device within 30 days that would interfere with the study goals prior to the Screening Visit
  • Unable to comply with study procedures in the opinion of the investigator

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo0921Placebo0921-
SPARC0921SPARC0921-
Primary Outcome Measures
NameTimeMethod
Treatment Failure RateWeek 22

Percentage of subjects who had treatment failure Clinical Global Impression of Change of β‰₯ 5 and at least one movement with β‰₯ 1 unit increase in modified Ashworth score from baseline.

The modified Ashworth scale is a 6-point scale as follows: Minimum score of 0 (better outcome) = no increase in tone Maximum score of 4 (worst outcome) = affected part(s) rigid inflexion or extension.

The clinician (other than the one performing the Modified Ashworth Scale assessment) rated his/her overall (global) impression of change in spasticity using the 7-point scale shown below: Minimum score of 1 (better outcome) = very much improved Maximum score of 7 (very much worse) = very much worse

Secondary Outcome Measures
NameTimeMethod
Severity of Spasticity Assessed by Subject Global Impression Severity ScaleWeek 22

The subject was asked "Overall, how would you rate the severity of your spasticity over the past 24 hours?" The 7-point scale for Subject's global impression of severity assessment is as follows: minimum score of 1 = normal, no spasticity maximum score of 7 (worst outcome)= worst spasticity imaginable

Trial Locations

Locations (73)

SPARC Site 56

πŸ‡ΊπŸ‡Έ

Columbus, Ohio, United States

SPARC Site 17

πŸ‡ΊπŸ‡Έ

Port Charlotte, Florida, United States

SPARC Site 36

πŸ‡ΊπŸ‡Έ

Costa Mesa, California, United States

SPARC Site 20

πŸ‡ΊπŸ‡Έ

Newport Beach, California, United States

SPARC Site 15

πŸ‡ΊπŸ‡Έ

Bradenton, Florida, United States

SPARC Site 19

πŸ‡ΊπŸ‡Έ

Sarasota, Florida, United States

SPARC Site 30

πŸ‡ΊπŸ‡Έ

Overland Park, Kansas, United States

SPARC Site 76

πŸ‡©πŸ‡ͺ

Erbach, Germany

SPARC Site 43

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

SPARC site 6

πŸ‡ΊπŸ‡Έ

Gilbert, Arizona, United States

SPARC Site 70

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

SPARC Site 64

πŸ‡ΊπŸ‡Έ

Detroit, Michigan, United States

SPARC Site 13

πŸ‡ΊπŸ‡Έ

Salt Lake City, Utah, United States

SPARC Site 57

πŸ‡ΊπŸ‡Έ

Hartford, Connecticut, United States

SPARC Site 10

πŸ‡ΊπŸ‡Έ

New London, Connecticut, United States

SPARC Site 60

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

SPARC Site 9

πŸ‡ΊπŸ‡Έ

Derby, Connecticut, United States

SPARC site 83

πŸ‡­πŸ‡Ί

Budapest, Hungary

SPARC Site 40

πŸ‡ΊπŸ‡Έ

Phoenix, Arizona, United States

SPARC Site 29

πŸ‡ΊπŸ‡Έ

Indian Land, South Carolina, United States

SPARC Site 81

πŸ‡­πŸ‡Ί

Eger, Hungary

SPARC Site 27

πŸ‡ΊπŸ‡Έ

Baton Rouge, Louisiana, United States

SPARC Site 86

πŸ‡·πŸ‡Ί

Novosibirsk, Russian Federation

SPARC Site 84

πŸ‡·πŸ‡Ί

Sestroretsk, Russian Federation

SPARC Site 55

πŸ‡ΊπŸ‡Έ

Stratford, New Jersey, United States

SPARC Site 73

πŸ‡ΊπŸ‡Έ

New Orleans, Louisiana, United States

SPARC Site 85

πŸ‡·πŸ‡Ί

Saint Petersburg, Russian Federation

SPARC Site 74

πŸ‡ΊπŸ‡Έ

Huntington, West Virginia, United States

SPARC Site 87

πŸ‡·πŸ‡Ί

Moscow, Russian Federation

SPARC Site 91

πŸ‡ΊπŸ‡¦

Poltava, Ukraine

SPARC Site 89

πŸ‡ΊπŸ‡¦

Zaporozh'ye, Ukraine

SPARC Site 21

πŸ‡ΊπŸ‡Έ

Denver, Colorado, United States

SPARC Site 38

πŸ‡ΊπŸ‡Έ

Basalt, Colorado, United States

SPARC Site 54

πŸ‡ΊπŸ‡Έ

Jacksonville, Florida, United States

SPARC Site 41

πŸ‡ΊπŸ‡Έ

Maitland, Florida, United States

SPARC Site 31

πŸ‡ΊπŸ‡Έ

Sunrise, Florida, United States

SPARC Site 39

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

SPARC Site 51

πŸ‡ΊπŸ‡Έ

Lenexa, Kansas, United States

SPARC Site 65

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

SPARC Site 50

πŸ‡ΊπŸ‡Έ

Louisville, Kentucky, United States

SPARC Site 42

πŸ‡ΊπŸ‡Έ

Alexandria, Louisiana, United States

SPARC Site 23

πŸ‡ΊπŸ‡Έ

Springfield, Massachusetts, United States

SPARC Site 35

πŸ‡ΊπŸ‡Έ

Foxboro, Massachusetts, United States

SPARC Site 32

πŸ‡ΊπŸ‡Έ

Clinton Township, Michigan, United States

SPARC Site 5

πŸ‡ΊπŸ‡Έ

Henderson, Nevada, United States

SPARC Site 25

πŸ‡ΊπŸ‡Έ

Golden Valley, Minnesota, United States

SPARC site 34

πŸ‡ΊπŸ‡Έ

Flemington, New Jersey, United States

SPARC Site 49

πŸ‡ΊπŸ‡Έ

Rochester, New York, United States

SPARC Site 45

πŸ‡ΊπŸ‡Έ

Charlotte, North Carolina, United States

SPARC Site 22

πŸ‡ΊπŸ‡Έ

Albuquerque, New Mexico, United States

SPARC Site 4

πŸ‡ΊπŸ‡Έ

Charlotte, North Carolina, United States

SPARC Site 24

πŸ‡ΊπŸ‡Έ

Greensboro, North Carolina, United States

SPARC Site 2

πŸ‡ΊπŸ‡Έ

Winston-Salem, North Carolina, United States

SPARC Site 75

πŸ‡ΊπŸ‡Έ

Winston-Salem, North Carolina, United States

SPARC Site 16

πŸ‡ΊπŸ‡Έ

Akron, Ohio, United States

SPARC Site 33

πŸ‡ΊπŸ‡Έ

Centerville, Ohio, United States

SPARC Site 12

πŸ‡ΊπŸ‡Έ

Eugene, Oregon, United States

SPARC Site 26

πŸ‡ΊπŸ‡Έ

Tacoma, Washington, United States

SPARC Site 7

πŸ‡ΊπŸ‡Έ

Austin, Texas, United States

SPARC Site 68

πŸ‡ΊπŸ‡Έ

Abington, Pennsylvania, United States

SPARC Site 44

πŸ‡ΊπŸ‡Έ

Springfield, Oregon, United States

SPARC Site 71

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

SPARC Site 67

πŸ‡ΊπŸ‡Έ

Waukesha, Wisconsin, United States

SPARC Site 69

πŸ‡ΊπŸ‡Έ

Milwaukee, Wisconsin, United States

SPARC Site 78

πŸ‡©πŸ‡ͺ

Westerstede, Germany

SPARC Site 77

πŸ‡©πŸ‡ͺ

Dresden, Germany

SPARC Site 79

πŸ‡©πŸ‡ͺ

Teupitz, Germany

SPARC Site 82

πŸ‡­πŸ‡Ί

Budapest, Hungary

SPARC Site 80

πŸ‡­πŸ‡Ί

Esztergom, Hungary

SPARC Site 88

πŸ‡·πŸ‡Ί

Stavropol', Russian Federation

SPARC Site 90

πŸ‡ΊπŸ‡¦

Dnipropetrovsk, Ukraine

SPARC Site 92

πŸ‡ΊπŸ‡¦

L'viv, Ukraine

SPARC Site 8

πŸ‡ΊπŸ‡Έ

Ormond Beach, Florida, United States

Β© Copyright 2025. All Rights Reserved by MedPath